Boston Scientific

BSX NYSE
Overview Stats Financials News

Quarterly Financials

Values in thousands 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Revenue $3,856,000 $3,725,000 $3,527,000 $3,599,000
Gross Profit 2,647,000 2,578,000 2,415,000 2,529,000
EBITDA 1,001,000 1,016,000 801,000 798,000
EBIT 697,000 703,000 593,000 588,000
Net Income 492,000 505,000 504,000 270,000
Net Change In Cash 3,856,000 3,725,000 3,527,000 3,599,000
Cost of Revenue -139,000
Free Cash Flow -81,000 690,000 492,000 452,000
Cash 2,329,000 865,000 952,000 426,000
Basic Shares 1,481,700 1,476,900 1,475,000 1,456,200

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue $14,240,000 $12,682,000 $11,888,000 $9,913,000
Gross Profit 9,895,000 8,679,000 8,128,000 6,403,000
EBITDA 3,620,000 2,800,000 2,784,000 1,833,000
EBIT 2,424,000 1,649,000 2,043,000 1,044,000
Net Income 1,593,000 698,000 1,041,000 -140,000
Net Change In Cash 14,240,000 12,682,000 11,888,000 9,913,000
Cost of Revenue -1,033,000 178,000 1,390,000
Free Cash Flow 1,703,000 914,000 1,316,000 1,132,000
Cash 865,000 928,000 1,925,000 1,734,000
Basic Shares 1,463,500 1,439,700 1,433,800 1,416,700

Earnings Calls

Quarter EPS
2024-03-31 $0.56
2023-12-31 $0.55
2023-09-30 $0.50
2023-06-30 $0.53